Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Ovarian Neoplasms

Free Subscription 09.07.2008 1 Am J Clin Pathol 1 Am J Surg Pathol 1 Cancer Chemother Pharmacol 2 Cancer Res 2 Eur J Gynaecol Oncol 5 Gynecol Oncol 1 Int J Cancer 2 J Clin Oncol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Clin Pathol

1. NOFECH-MOZES S , Ackerman I, Ghorab Z, Ismiil N, et al
   Lymphovascular invasion is a significant predictor for distant recurrence in patients with early-stage endometrial endometrioid adenocarcinoma.
   Am J Clin Pathol. 2008;129:912-7.
   PubMed     Related articles    Abstract available
   
   

   
   Am J Surg Pathol

2. HE H , Luthringer DJ, Hui P, Lau SK, et al
   Expression of CD56 and WT1 in Ovarian Stroma and Ovarian Stromal Tumors.
   Am J Surg Pathol. 2008;.
   PubMed     Related articles    Abstract available
   
   

   
   Cancer Chemother Pharmacol

3. DUAN Z , Ames RY, Ryan M, Hornicek FJ, et al
   CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells.
   Cancer Chemother Pharmacol. 2008;.
   PubMed     Related articles    Abstract available
   
   

   
   Cancer Res

4. BONOME T , Levine DA, Shih J, Randonovich M, et al
   A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer.
   Cancer Res. 2008;68:5478-86.
   PubMed     Related articles    Abstract available
   
   
5. KIKUCHI R , Tsuda H, Kozaki K, Kanai Y, et al
   Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer.
   Cancer Res. 2008;68:5067-75.
   PubMed     Related articles    Abstract available
   
   

   
   Eur J Gynaecol Oncol

6. MA CJ , Yang SF, Huang CC, Chai CY, et al
   Malignant mixed mullerian tumor of primary mesenteric origin associated with a synchronous ovarian cancer: case report and literature review.
   Eur J Gynaecol Oncol. 2008;29:289-93.
   PubMed     Related articles    Abstract available
   
   
7. LI M , Wang B, Lin W
   Cl-channel blockers inhibit cell proliferation and arrest the cell cycle of human ovarian cancer cells.
   Eur J Gynaecol Oncol. 2008;29:267-71.
   PubMed     Related articles    Abstract available
   
   

   
   Gynecol Oncol

8. TAYLOR DD , Gercel-Taylor C
   MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.
   Gynecol Oncol. 2008;110:13-21.
   PubMed     Related articles    Abstract available
   
   
9. JOHNSON CC , Kessel B, Riley TL, Ragard LR, et al
   The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial.
   Gynecol Oncol. 2008;.
   PubMed     Related articles    Abstract available
   
   
10. MARKMAN M
    Mandating prospectively defined endpoints for ovarian cancer phase 2 trials: A strategy to improve the quality of gynecologic cancer clinical research.
    Gynecol Oncol. 2008;.
    PubMed     Related articles   
    
    
11. PARK JY , Kim DY, Suh DS, Kim JH, et al
    Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: Oncologic safety and reproductive outcomes.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
12. HAVRILESKY LJ , Whitehead CM, Rubatt JM, Cheek RL, et al
    Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    

    
    Int J Cancer

13. YOSHIMOTO M , Ogawa K, Washiyama K, Shikano N, et al
    alpha(v)beta(3) Integrin-targeting radionuclide therapy and imaging with monomeric RGD peptide.
    Int J Cancer. 2008;123:709-15.
    PubMed     Related articles    Abstract available
    
    

    
    J Clin Oncol

14. WEBERPALS JI , Clark-Knowles KV, Vanderhyden BC
    Sporadic epithelial ovarian cancer: clinical relevance of BRCA1 inhibition in the DNA damage and repair pathway.
    J Clin Oncol. 2008;26:3259-67.
    PubMed     Related articles    Abstract available
    
    
15. SEHOULI J , Stengel D, Oskay-Oezcelik G, Zeimet AG, et al
    Nonplatinum topotecan combinations versus topotecan alone for recurrent ovarian cancer: results of a phase III study of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group.
    J Clin Oncol. 2008;26:3176-82.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: